RAPP
Rapport Therapeutics, Inc. Common Stock
NASDAQ · USHealthcareBiotechnology
$41.74-2.06%
Price as of Jul 20, 2026
RAPP earnings
Rapport Therapeutics, Inc. Common Stock earnings
Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.
Next earnings
Aug 6, 2026in NaN days
EPS est $-0.96 · Revenue est $2M
Track record
Beat EPS in 6 of 8 quarters
Avg surprise +9.0% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 7, 2026 | $-0.56 | $-0.42 | +25.0% | $20M | +166.7% |
| Mar 10, 2026 | $-0.65 | $-0.72 | -10.6% | — | — |
| Nov 6, 2025 | $-0.77 | $-0.71 | +7.8% | — | — |
| Aug 7, 2025 | $-0.87 | $-0.75 | +13.8% | — | — |
| May 8, 2025 | $-0.77 | $-0.68 | +11.7% | — | — |
| Mar 11, 2025 | $-0.62 | $-0.57 | +8.1% | — | — |
| Nov 7, 2024 | $-0.57 | $-0.50 | +12.3% | — | — |
| Aug 8, 2024 | $-0.68 | $-1.70 | -150.0% | — | — |
| Mar 30, 2024 | — | $-0.12 | — | — | — |
| Sep 30, 2023 | — | $-0.05 | — | — | — |
Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-06.